Publications (since 2000)

Originals

  • Aschacher T, Sampl S, Käser L, Berhard D, Spittler A, Holzmann K, Bergmann M. The combined use of known antiviral resverse transcriptase inhibitors AZT and DDI induce anticancer effects at low concentrations. Neoplasia. 2012 Jan;14(1):44-53.
  • Blunder S, Messner B, Aschacher T, Zeller I, Türkcan A, Wiedemann D, Andreas M, Blüschke G, Laufer G, Schachner T, Bernhard D. Characteristics of TAV- and BAV-associated thoracic aortic aneurysms-Smooth muscle cell biology, expression profiling, and histological analyses. Atherosclerosis, 2012 Feb;220(2):355-61. Epub 2011 Nov 28.
  • Petricevic B, Vrbanec D, Jakic-Razumovic J, Brcic I, Rabic D, Badovinac T, Ozimec E und Bali V. Expression of Toll-like receptor 4 and beta 1 integrin in breast cancer. Med. Oncology Epub March 2011
  • Wolschek M, Samm E, Sturlan S,Schwager C, Khassidov A, Kittel C, Muster T, Egorov A, Bergmann M. Establishment of a chimeric, replication defective influenza A virus vector by modulation of splice sites. J Virol. 2011 Mar;85(5):2469-73.
  • Riss S, Stremitzer S, Riss K, Mittlböck M, Bergmann M, Stift A. Pelvic organ function and quality of life after anastomotic leakage following rectal cancer surgery. Wien Klin Wochenschr. 2011 Jan;123(1-2):53-7.
  • Wacheck V, Egorov A, Groiss F, Pfeiffer T, Fuereder T, Hoeflmayer D, Kundi K, Popow-Kraupp T, Redlberger-Fritz M, Mueller CA, Cinatl J, Michaelis M, Geiler J, Bergmann M, Romanova J, Roethl J, Morokutti A, Wolschek M, Ferko B, Seipelt J for the FluVacc EU consortium, Dick-Gudenus R, Muster T. A novel type of live vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1. J Infect Dis. 2010 Feb 1;201(3):354-62.
  • Riss S, Stift A, Meier M, Haiden E, Grünberger T, Bergmann M. Endo-sponge assisted treatment of anastomotic leakage following colorectal surgery. Colorectal Dis. 2010 Jul;12(7 Online):e104-8.
  • Stremitzer S, Bachleitner-Hofmann T, Bachleitner-Hofmann B, Gradl B, Gruenbeck M, Mittlboeck M, , Bergmann M. Treatment of mesh graft infection following abdominal hernia repair. Risk factor evaluation, strategy and influence of the type of mesh used. A retrospective analysis of 478 operations. World J Surg. 2010 Jul;34(7):1702-9.
  • Riss S, Sift A, Kienbacher C, Dauser B, Haunold I, Kriwanek S, Radlsboek W, Bergmann M. Recurrent-abcess after primary successful endo-sponge assisted treatment of anastomotic leakage after rectal cancer surgery – long term results of a multicenter study. World J Gastroenterol. 2010 Sep 28;16(36):4570-4.
  • Sturlan S., Stremitzer S, Baumann S, Sachet M, Wolschek M, Egorov A, Bergmann M. Endogenous expression of proteases in colon cancer cells facilitate influenza A viruses mediated oncolysis. Cancer Biology and Therapy 2010 Sep 2;10(6).
  • Michlmayr A, Bachleitner-Hofmann T, Baumann S, , Burghuber C, Pluschnig U, Bartsch R, Wenzel C, Altorjai G, Forstner H, Steger G, Gnant M, Bergmann M*, Oehler R.. Modulation of serum complement predicts response to neoadjuvant epirubicin/doxetacel based chemotherapy in breast cancer patients. Br. J. Cancer 2010; 103(8):1201-8 (*corr. author)
  • Sturlan S, Sachet M, Baumann S, Kuznetsova I, Spittler A, Bergmann M. Influenza A Virus Induces an Immediate Cytotoxic Activity in All Major Subsets of Peripheral Blood Mononuclear Cells. PLoS ONE 2009 Jan 4(1): e4122
  • Sachet M, Friedl J, Hassler M, Ploder M, Stary G, Stift A, Bergmann M. Improvement of a dendritic cell-based tumour vaccine by an influenza virus 2009. Eurp. J Clin Investigation 39(11): 1000-1009.
  • Petricevic B, Wessner B, Sachet M, Vrbanec D, Spittler A, Bergmann, M. 2009. CL097, a TLR7/8 ligand, iinhibits TLR-4-Dependent activation of Irak-M and BCL-3 expression. Shock 32(5): 484-490.
  • Romanova J, Krenn BM, Wolschek M, Ferko B, Romanovskaja-Romanko E, Morokutti A, Shurygina AP, Nakowitsch S, Ruthsatz T, Kiefmann B, König U, Bergmann M, Sachet M, Balasingam S, Mann A, Oxford J, Slais M, Kiselev O, Muster T, Egorov A. Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine. PLoS One 2009. Jun 19;4(6):e5984
  • Hayden H, Friedl J, Dettke M, Sachet M, Hassler M, Dubsky P, Bachleitner-Hofmann T, Gnant M, Stift A. Cryopreservation of monocytes is superior to cryopreservation of immature or semi-mature dendritic cells for dendritic cell-based immunotherapy J Immunother. 2009 Jul-Aug;32(6):638-54.
  • Schrauf C, Kirchberger S, Majdic O, Seyerl M, Zlabinger GJ, Stuhlmeier KM, Sachet M, Seipelt J, Stöckl J. The ssRNA genome of human rhinovirus induces a type I IFN response but fails to induce maturation in human monocyte-derived dendritic cells. J Immun. 2009, 183, 4440 -4448.
  • Bachleitner-Hofmann T, Friedl J, Hassler M, Hayden H, Dubsky P, Sachet M, Rieder E, Pfragner R, Brostjan C, Riss S, Niederle B, Gnant M, Stift A. Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma. Oncol Rep. 2009 Jun;21(6):1585-92
  • Dubsky P, Hayden H, Sachet M, Bachleitner-Hofmann T, Hassler M, Pfragner R, Gnant M, Stift A, Friedl J. Allogeneic tumor lysate can serve as both antigen source and protein supplementation for dendritic cell culture. Cancer Immunol Immunother. 2008 Jun;57(6):859-70. Epub 2007 Nov 21.
  • Hoetzenecker K, Hacker S, Hoetzenecker W, Sadeghi K, Sachet M, Pollreisz A, Mangold A, Wliszczak T, Bielek E, Muehlbacher F, Klepetko W, Ankersmit HJ Cytomegalovirus hyperimmunoglobulin: mechanisms in allo-immune response in vitro. Eur J Clin Invest. 2007 Dec;37(12):978-86.
  • Bachleitner-Hofmann T, Strohschneider M, Krieger P, Sachet M, Dubsky P, Hayden H, Schoppmann SF, Pfragner R, Gnant M, Friedl J, Stift A. Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma. J Clin Endocrinol Metab. 2006 Nov;91(11):4571-7. Epub 2006 Sep 5.
  • Humer J,Waltenberger A, Grassauer A, Kurz M,Valencak J,Rapberger R, Hahn S, Bergmann M, Löwer R, Wolff K, Muster T, Mayer B and Pehamberger H, 2006. Identification of a Melanoma Marker Derived from Melanoma-Associated Endogenous Retroviruses. Cancer Res. 2006; 66: (3): 1658-1663
  • Wolf B, Gruber S, Henglmueller S, Kappel S, Bergmann M, Wrba F and Karner-Hanusch J. 2006. Efficiency of the revised Bethesda guidelines for the detection of mutations in mismatch repair genes in Austrian HNPCC patients. Int J Cancer 2006;.118(6):1465-70.
  • Wolf B, Henglmueller S, Janschek E, Ilencikova D, Ludwig-Papst C, Bergmann M, Mannhalter C, Wrba F, and Karner-Hanusch J. Spectrum of germ-line MLH1 and MSH2 mutations in Austrian patients with hereditary nonpolyposis colorectal cancer. Wiener Klinische Wochenschrift 2005; 117 (7-8) 269-277
  • Stift A, Sachet M, Yagubian R, Bittermann C, Dubsky P, Brostjan C, Pfragner R, Niederle B, Jakesz R, Gnant M, Friedl J. Dendritic cell vaccination in medullary thyroid carcinoma. Clin Cancer Res. 2004 May 1;10(9):2944-53.
  • Muster T, Rajtarova J, Sachet M, Unger H, Fleischhacker R, Romirer I, Grassauer A, Url A, Garcia-Sastre A, Wolff K, Pehamberger H and Bergmann M. Interferon resistance promotes oncolysis by influenza virus NS1-deletion mutants. Int J Cancer 2004; 110(1):15-21
  • Bergmann M, Gornikiewicz A, Tamandl D, Exner R, Roth E, Fugger R, Gotzinger P and Sautner T. Continuous therapeutic epinephrine but not norepinephrine prolongs splanchnic IL-6 production in porcine endotoxic shock. Shock 2003; 20(6):575-81.
  • Stift A, Prager G, Selzer E, Widder J, Kandioler D, Friedl J, Teleky B, Herbst F, Wrba F and Bergmann M. The early response of p53-dependent proteins during radiotherapy in human rectal carcinoma and in adjacent normal tissue. Int J Oncol. 2003 Nov;23(5):1269-75.
  • Spittler A., T. Sautner, A. Gornikiewicz, N. Manhart, R. Oehler , M. Bergmann, R. Függer and E. Roth. Postoperative glycyl-glutamine infusion reduces immunosuppression: partial prevention of the surgery induced decrease in HLA-DR expression on monocytes. Clin Nutr 2001; 20:37-42.
  • Bergmann M., I. Romirer, M. Sachet, R. Fleischhacker, A. García-Sastre, P. Palese, K, Wolff, H. Pehamberger, R. Jakesz and T. Muster. A genetically engineered influenza A virus with ras-dependent oncolytic properties. Cancer Res. 2001; 61: 8188-8193.
  • Böhmig G., T. Saemann, M. Bergmann, B. Watschinger, H. Regele, T. Windhager, F. Mühlbacher, W.H. Hörl. and G. Zlabinger. Long-term evaluation of proliferative donor antigen-specific reactivity in cadaveric kidney transplant recipients. Transplant International 2000; 13: 187-193.
  • Bergmann M., I. Romierer, A. Garcia-Sastre, B. Jansen, H. Pehamberger, P. Palese, and T. Muster. The role of the NS1/PKR interaction in influenza A virus infection. J. of Virology 2000; 74: 6203-6206
  • Gornikiewicz, A., T. Sautner, C. Brostjan, B. Schmierer, R. Függer, E. Roth, F. Mühlbacher, and M. Bergmann. Catecholamines upregulate lipopolysaccaride-induced IL-6 production in human microvascular endothelial cells. FASEB-J 2000; 14: 1093-1100.
  • Öehler R., G. Weingartmann, N. Manhart, U. Salzer, M. Meissner, W. Schlegel, A. Spittler, M. Bergmann, D. Kandioler, C. Oismüller, H.M. Struse and E. Roth. Polytrauma induces increased expression of pyruvate kinase in neutrophils. Blood 2000; 95, 1086-1092.

Reviews/ Book chapters

  • Michlmayr A, Bachleitner-Hofmann T, Bergmann M, Oehler R. Reply: Modulation of plasma complement by initial dose of epirubilcin/docetaxel therapy in breat cacner and its predictive value. Br. J Cacner, 2011, Jan 11
  • Bergmann M, Wolf B and Karner-Hanusch J. 2006. Hereditary colorectal cancer – guidelines for clinical routine. Eur Surg 2006; 38/1: 59-62
  • Muster T and Bergmann M. 2005. Influenza A viruses with deletions the NS1 gene – a rational design for oncolytic virues. In „Viral Therapy of Human Cancer “ Eds: J.G. Szinkovics and J.C. Horvath. Marcel Dekker, New York. pp 575-596.
  • Bergmann M and Sautner T. 2002. Immunologische Nebenwirkungen von Katecholaminen. Intensiv-News 6 (2):4-5.
  • Bergmann M and Sautner T. 2002. Immunomodulatory effects of vasoactive catecholamines. Wiener Klinische Wochenzeitschrift. Wien Klin Wochenschr. 2002; Sep 30;114(17-18):752-61.

Patents

  • Wolschek M, Egorov A, Bergmann M, Muster T. High growth USA reassortant influenza virus. USA 61/138819 filed Dec 2009.
  • Wolschek M, Egorov A, Bergmann M, Muster T, Kittel C. Novel viral vector for the expression of heterologous sequences. EP 074501.8, USA 60/946,644 filed Oct 2007; PCT/EP2008/58154 filed Jun 2008
  • Wolschek M, Egorov A, Bergmann M, Muster T, Kittel C. Linear expression contructs for production of influenza virus particles. EP 07450177.6, USA 60/946,651 filed Oct 07, PCT/EP2008/058182 filed Jun 2008
  • Sachet M, Bergmann M, Muster T, Egorov A. Immune response inducing preparations. A1332/2005 filed Aug 2005, PCT/AT2006/000335, filed Aug 2006, WO 2007/016715 A2.
  • Palese P, Enami M, Muster T, Bergmann M. Genetically engineered attenuated viruses. PCT/US93/03615 filed Dec 1994, US Patent 6,022,726 issued Feb 2000